SCHEMBL366570

SCHEMBL366570

CS(=O)(=O)NC(=O)c1ccc(OCc2ccc(OC(F)(F)F)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.58
MMP2 P08253 1/20 0.58
MMP9 P14780 1/20 0.58
MMP14 P50281 1/20 0.58
ADAM17 P78536 1/20 0.58
MRGPRX4 Q96LA9 2/20 0.53
MAOB P27338 2/20 0.52
SCN9A Q15858 2/20 0.52
SCN5A Q14524 1/20 0.52
EPHX2 P34913 1/20 0.51
NR1H4 Q96RI1 1/20 0.51
ALDH1A1 P00352 2/20 0.50
MAPT P10636 2/20 0.50
MAPK1 P28482 1/20 0.50
HTT P42858 1/20 0.50
CYP19A1 P11511 1/20 0.49
CYP11B1 P15538 1/20 0.49
CYP11B2 P19099 1/20 0.49
HDAC3 O15379 1/20 0.49
HDAC1 Q13547 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL366467 0.87 MMP2 (0.60) MMP2MMP9MMP14ADAM17MRGPRX4
SCHEMBL364340 0.87 RXRA (0.62) SCN9AALDH1A1MAPTMAPK1HTT
SCHEMBL366812 0.86 MAOB (0.63) MMP1MMP2MMP9MMP14ADAM17
SCHEMBL16239768 0.84 ALDH1A1 (0.70) ADAM17SCN9AALDH1A1MAPTMAPK1
SCHEMBL365645 0.84 ALDH1A1 (0.70) ADAM17SCN9AALDH1A1MAPTMAPK1
SCHEMBL678827 0.84 SCN9A (0.58) MMP9MMP14SCN9ASCN5AEPHX2
SCHEMBL365210 0.83 MAOA (0.63) MMP2MMP9MAOBSCN9ASCN5A
SCHEMBL366081 0.83 MAOA (0.63) MMP2MMP9MAOBSCN9ASCN5A
SCHEMBL365173 0.83 MAOB (0.61) MAOBNR1H4ALDH1A1MAPTHDAC3
Diethylamine SCHEMBL16239678 0.82 RXRA (0.57) SCN9AALDH1A1MAPTMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096500-B2 Acyl sulfonamide compounds PFIZER LIMITED (GB) 2015-08-04 US disclosed
EP-2593428-B1 N-SULFONYLBENZAMIDES AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS PFIZER LTD (GB) 2014-11-19 EP disclosed
EP-2593428-A2 N-SULFONYLBENZAMIDES AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS Pfizer Limited (GB) 2013-05-22 EP disclosed
US-20130109701-A1 Chemical Compounds PFIZER LIMITED (GB) 2013-05-02 US disclosed
WO-2012007868-A2 CHEMICAL COMPOUNDS PFIZER LIMITED (GB) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130109701-A1 Chemical Compounds SCN1A, SCN1B, SCN7A MMP1 2825/4885MMP2 4523/4885MMP9 3983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.